Benefit-Risk Assessment Methods in Medical Product Development

Benefit-Risk Assessment Methods in Medical Product Development
Author :
Publisher : CRC Press
Total Pages : 208
Release :
ISBN-10 : 9781315355016
ISBN-13 : 1315355019
Rating : 4/5 (019 Downloads)

Book Synopsis Benefit-Risk Assessment Methods in Medical Product Development by : Qi Jiang

Download or read book Benefit-Risk Assessment Methods in Medical Product Development written by Qi Jiang and published by CRC Press. This book was released on 2017-12-19 with total page 208 pages. Available in PDF, EPUB and Kindle. Book excerpt: Guides You on the Development and Implementation of B–R Evaluations Benefit–Risk Assessment Methods in Medical Product Development: Bridging Qualitative and Quantitative Assessments provides general guidance and case studies to aid practitioners in selecting specific benefit–risk (B–R) frameworks and quantitative methods. Leading experts from industry, regulatory agencies, and academia present practical examples, lessons learned, and best practices that illustrate how to conduct structured B–R assessment in clinical development and regulatory submission. The first section of the book discusses the role of B–R assessments in medicine development and regulation, the need for both a common B–R framework and patient input into B–R decisions, and future directions. The second section focuses on legislative and regulatory policy initiatives as well as decisions made at the U.S. FDA’s Center for Devices and Radiological Health. The third section examines key elements of B–R evaluations in a product’s life cycle, such as uncertainty evaluation and quantification, quantifying patient B–R trade-off preferences, ways to identify subgroups with the best B–R profiles, and data sources used to assist B–R assessment. The fourth section equips practitioners with tools to conduct B–R evaluations, including assessment methodologies, a quantitative joint modeling and joint evaluation framework, and several visualization tools. The final section presents a rich collection of case studies. With top specialists sharing their in-depth knowledge, thought-provoking considerations, and practical advice, this book offers comprehensive coverage of B–R evaluation methods, tools, and case studies. It gives practitioners a much-needed toolkit to develop and conduct their own B–R evaluations.


Benefit-Risk Assessment Methods in Medical Product Development Related Books

Benefit-Risk Assessment Methods in Medical Product Development
Language: en
Pages: 208
Authors: Qi Jiang
Categories: Mathematics
Type: BOOK - Published: 2017-12-19 - Publisher: CRC Press

GET EBOOK

Guides You on the Development and Implementation of B–R Evaluations Benefit–Risk Assessment Methods in Medical Product Development: Bridging Qualitative and
Benefit-Risk Assessment Methods in Medical Product Development
Language: en
Pages: 313
Authors: Qi Jiang
Categories: Mathematics
Type: BOOK - Published: 2017-12-19 - Publisher: CRC Press

GET EBOOK

Guides You on the Development and Implementation of B–R Evaluations Benefit–Risk Assessment Methods in Medical Product Development: Bridging Qualitative and
Platform Trial Designs in Drug Development
Language: en
Pages: 323
Authors: Zoran Antonijevic
Categories: Mathematics
Type: BOOK - Published: 2018-12-07 - Publisher: CRC Press

GET EBOOK

Platform trials test multiple therapies in one indication, one therapy for multiple indications, or both. These novel clinical trial designs can dramatically in
Benefit-Risk Assessment of Medicines
Language: en
Pages: 326
Authors: James Leong
Categories: Medical
Type: BOOK - Published: 2015-04-21 - Publisher: Springer

GET EBOOK

This book proposes and investigates a universal framework, and accompanying documentation system, to facilitate and catalogue benefit-risk decisions; a valuable
Encyclopedia of Biopharmaceutical Statistics - Four Volume Set
Language: en
Pages: 2434
Authors: Shein-Chung Chow
Categories: Medical
Type: BOOK - Published: 2018-09-03 - Publisher: CRC Press

GET EBOOK

Since the publication of the first edition in 2000, there has been an explosive growth of literature in biopharmaceutical research and development of new medici